BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8327329)

  • 1. [Detection of bone involvement in malignant diseases by immunoscintigraphy of the bone marrow].
    Reske SN; Karstens JH; Henrich MM; Sohn M; Glöckner W; Jakse G; Büll U
    Nuklearmedizin; 1993 Jun; 32(3):111-9. PubMed ID: 8327329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow immunoscintigraphy compared with conventional bone scintigraphy for the detection of bone metastases.
    Reske S; Kartsens J; Sohn M; Glöckner W; Buell U
    Acta Oncol; 1993; 32(7-8):753-61. PubMed ID: 8305223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of bone marrow involvement in breast cancer and malignant lymphoma using immunoscintigraphy of the hematopoietic bone marrow].
    Reske SN; Karstens JH; Glöckner WM; Ammon J; Büll U
    Rofo; 1990 Jan; 152(1):60-6. PubMed ID: 2154012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow immunoscintigraphy versus conventional bone scintigraphy in the diagnosis of skeletal metastases in urogenital malignancies.
    Zoeller G; Sandrock D; Munz DL; Ringert RH
    Eur Urol; 1994; 26(2):141-4. PubMed ID: 7957469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technetium-99m-labeled antigranulocyte antibody bone marrow scintigraphy.
    Lee KH; Chung JK; Choi CW; Jeong JM; Lee DS; Bang YJ; Lee MC; Kim NK; Koh CS
    J Nucl Med; 1995 Oct; 36(10):1800-5. PubMed ID: 7562046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow immunoscintigraphy for the detection of skeletal metastases in patients with breast cancer.
    Lacić M; Bokulić T; Lukac J; Kovacić K; Baum RP; Kusić Z
    Nucl Med Commun; 1999 Feb; 20(2):135-43. PubMed ID: 10088162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow immunoscintigraphy using technetium-99m anti-granulocyte antibody in multiple myeloma.
    Sohn SK; Ahn BC; Lee SW; Kim DH; Chun KA; Kim JG; Park SH; Song HS; Lee B; Lee J
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):591-6. PubMed ID: 11976796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
    Limouris GS; Voliotopoulos V; Stavraka A; Vlahos L
    Anticancer Res; 1997; 17(3B):1615-8. PubMed ID: 9179204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative diagnostic accuracy of magnetic resonance imaging and immunoscintigraphy for detection of bone marrow involvement in patients with malignant lymphoma.
    Altehoefer C; Blum U; Bathmann J; Wüstenberg C; Uhrmeister P; Laubenberger J; Lange W; Schwarzkopf J; Moser E; Langer M
    J Clin Oncol; 1997 May; 15(5):1754-60. PubMed ID: 9164182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunoimaging for diagnosis of bone marrow involvement in breast cancer and malignant lymphoma.
    Reske SN; Karstens JH; Gloeckner W; Steinsträsser A; Schwarz A; Ammon J; Buell U
    Lancet; 1989 Feb; 1(8633):299-301. PubMed ID: 2563458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigranulocyte antibody bone marrow scans in cancer patients with metastatic bone superscan appearance.
    Berná L; Torres G; Carrió I; Estorch M; Germá JR; Alonso C
    Clin Nucl Med; 1994 Feb; 19(2):121-8. PubMed ID: 8187396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radionuclide imaging of bone marrow metastases with a Tc-99m labeled monoclonal antibody to small cell lung carcinoma.
    Balaban EP; Walker BS; Cox JV; Sein AA; Abrams PG; Salk D; Sheehan RG; Frenkel EP
    Clin Nucl Med; 1991 Oct; 16(10):732-6. PubMed ID: 1660386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmune imaging of bone marrow in patients with suspected bone metastases from primary breast cancer.
    Duncker CM; Carrió I; Berná L; Estorch M; Alonso C; Ojeda B; Blanco R; Germá JR; Ortega V
    J Nucl Med; 1990 Sep; 31(9):1450-5. PubMed ID: 2168473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone scanning and radiography in the evaluation of patients with malignant lymphoma.
    Jánoskuti L; Szilvási I; Papp G; Róna E; Benedek S; Fekete S
    Rofo; 1988 Oct; 149(4):427-8. PubMed ID: 2845515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marrow scintigraphic changes after hormonal therapy.
    Bourgeois P; Malarme M; Wauters E; Van Frank R; Ferremans W
    J Nucl Med; 1992 Jul; 33(7):1427-8. PubMed ID: 1613591
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of skeletal scintigraphy and bone marrow scintigraphy in detection of osseous metastases].
    Bathmann J; Moser E
    Radiologe; 1995 Jan; 35(1):8-14. PubMed ID: 7892445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoscintigraphy of the bone marrow: normal uptake values of technetium-99m-labeled monoclonal antigranulocyte antibodies.
    Huić D; Ivancević V; Richter WS; Munz DL
    J Nucl Med; 1997 Nov; 38(11):1755-8. PubMed ID: 9374347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generalized bone marrow metastases. High liver uptake on bone marrow immunoscintigraphy associated with extramedullary hematopoiesis.
    Brans B; Roland J; De Meyer P; Servais J; Goethem JV; Scalliet P
    Clin Nucl Med; 1996 Jan; 21(1):40-2. PubMed ID: 8741888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photopenic lesions in bone marrow scintigraphy using technetium-99m labeled antigranulocyte antibody without known tumour.
    Krause T; Reinhardt M; Nitzsche E; Moser E
    Nuklearmedizin; 1999 Apr; 38(3):85-9. PubMed ID: 10320994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of bone-marrow scanning with technetium-99m sulfur colloid in pediatric oncology.
    Siddiqui AR; Oseas RS; Wellman HN; Doerr DR; Baehner RL
    J Nucl Med; 1979 May; 20(5):379-86. PubMed ID: 232146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.